Patents 93show all

  • 30
    C07D - Heterocyclic compounds
  • 15
    A61K - Preparations for medical, dental, or toilet purposes
  • 11
    C07C - Acyclic or carbocyclic compounds
  • 5
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 4
    C12N - Microorganisms or enzymes
  • 3
    C07K - Peptides
  • 2
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 2
    Y02A - Technologies for adaptation to climate change

SEC Filings show all


3
D

Contact Information

SEC Form D Funding Events

DateOfferedSoldType
2010-05-14$8,500,000$3,916,229Equity, Option to Acquire
2009-06-12$20,000,000$9,259,078Debt
2007-07-16Unknown Unknown Other (Paper Filing)

Key Executives

  • Peter R. Dolan
    Executive Officer, Director
  • Gordon C. Shore
    Executive Officer, Director
  • D. Michael Dixon
    Executive Officer
  • Jean Viallet
    Executive Officer
  • Robert G. McNeil
    Director
  • Timothy J. Barberich
    Director
  • Aaron Davidson
    Director
  • Robert Gorman
    Director
  • Andrew R. Jordan
    Director
  • Eric W. Roberts
    Director
  • Scott Morenstein
    Director